EXTRANODAL DISEASE IS ASSOCIATED WITH SHORTER PROGRESSION‐FREE SURVIVAL AFTER CD19‐CAR T‐CELL THERAPY FOR RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA. (17th June 2021) - Bücklein, V.; Blumenberg, V.; Ackermann, J.; Frölich, L.; Winkelmann, M.; Schmidt, C.; Rejeski, K.; Ruzicka, M.; Müller, N.; von Baumgarten, L.; Schöberl, F.; Hildebrandt, M.; et al.